Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NORTHWEST BIOTHERAPEUTICS INCNWBO · Entity 5982 | Director · CHIEF SCIENTIFIC OFFICER | August 29, 2024 | September 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NORTHWEST BIOTHERAPEUTICS INC
Report date August 29, 2024 · Filed September 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| STOCK OPTIONSSEC Table II · derivative / convertible security · Conversion / exercise price $0.23 · Expires 2028-08-31 | Direct | 967,065 |
Reported balance
After 2024-08-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-08-29 · Gift · Disposed 1,000,000 · Balance 967,065 F1: GIFT FROM DR. BOYNTON TO FAMILY MEMBERS WHO DO NOT SHARE SAME RESIDENCE FOR ESTATE PLANNING PURPOSES |
Filing footnotes · ownership attribution and instrument terms
F1: GIFT FROM DR. BOYNTON TO FAMILY MEMBERS WHO DO NOT SHARE SAME RESIDENCE FOR ESTATE PLANNING PURPOSES
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 29, 2024 Filed Sep 3, 2024 20:01 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GiftSTOCK OPTIONS · Derivative | 1,000,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001104659-24-096354 · tm2423270-1_4seq1.xml · derivative · entry 1 BOYNTON ALTON L · CIK 0001253935 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 967,065 Underlying: COMMON STOCK PAR VALUE $0.001 · 1,000,000 shares Expires 2028-08-31 F1 · kind: GIFT FROM DR. BOYNTON TO FAMILY MEMBERS WHO DO NOT SHARE SAME RESIDENCE FOR ESTATE PLANNING PURPOSES Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 20:30 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GiftSTOCK OPTIONS · Derivative | 1,000,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001104659-24-087304 · tm2421126-1_4seq1.xml · derivative · entry 1 BOYNTON ALTON L · CIK 0001253935 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,967,065 Underlying: COMMON STOCK PAR VALUE $0.001 · 2,967,065 shares Expires 2028-08-31 F1 · kind: GIFT FROM DR. BOYNTON TO FAMILY MEMBERS WHO DO NOT SHARE SAME RESIDENCE FOR ESTATE PLANNING PURPOSES Read SEC document |
| April 04, 2023 Filed Apr 5, 2023 13:30 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GiftSTOCK OPTIONS · Derivative | 6,794,191 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001104659-23-041927 · tm2311802-1_4seq1.xml · derivative · entry 1 BOYNTON ALTON L · CIK 0001253935 · Director · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,967,065 Underlying: COMMON STOCK PAR VALUE $0.001 · 6,794,191 shares Expires 2030-07-02 F1 · kind: GIFT FROM DR. BOYNTON TO FAMILY MEMBERS WHO DO NOT SHARE SAME RESIDENCE FOR ESTATE PLANNING PURPOSES Read SEC document |
| December 06, 2022 Filed Feb 7, 2023 22:55 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GiftCOMMON STOCK OPTIONS · Derivative | 4,500,000 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001104659-23-011814 · tm235861-1_5seq1.xml · derivative · entry 4 BOYNTON ALTON L · CIK 0001253935 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,761,256 Underlying: COMMON STOCK PAR VALUE $0.001 · 4,500,000 shares Expires 2030-12-01 F1 · kind: GIFTS FROM DR. BOYNTON FOR ESTATE PLANNING PURPOSES. Read SEC document |
| December 06, 2022 Filed Feb 7, 2023 22:55 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GiftCOMMON STOCK OPTIONS · Derivative | 4,500,000 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001104659-23-011814 · tm235861-1_5seq1.xml · derivative · entry 3 BOYNTON ALTON L · CIK 0001253935 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,761,256 Underlying: COMMON STOCK PAR VALUE $0.001 · 4,500,000 shares Expires 2030-12-01 F1 · kind: GIFTS FROM DR. BOYNTON FOR ESTATE PLANNING PURPOSES. Read SEC document |
| July 27, 2022 Filed Feb 7, 2023 22:55 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GiftCOMMON STOCK OPTIONS · Derivative | 3,000,000 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001104659-23-011814 · tm235861-1_5seq1.xml · derivative · entry 2 BOYNTON ALTON L · CIK 0001253935 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,761,256 Underlying: COMMON STOCK PAR VALUE $0.001 · 3,000,000 shares Expires 2030-12-01 F1 · kind: GIFTS FROM DR. BOYNTON FOR ESTATE PLANNING PURPOSES. Read SEC document |
| May 26, 2022 Filed Feb 7, 2023 22:55 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GiftCOMMON STOCK OPTIONS · Derivative | 4,900,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001104659-23-011814 · tm235861-1_5seq1.xml · derivative · entry 1 BOYNTON ALTON L · CIK 0001253935 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,761,256 Underlying: COMMON STOCK PAR VALUE $0.001 · 4,900,000 shares Expires 2028-05-28 F1 · kind: GIFTS FROM DR. BOYNTON FOR ESTATE PLANNING PURPOSES. Read SEC document |
| January 19, 2021 Filed Jan 19, 2021 21:06 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GiftEmployee Stock Option (Right to Buy) · Derivative | 3,402,935 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001104659-21-005311 · tm213558d1_4.xml · derivative · entry 1 BOYNTON ALTON L · CIK 0001253935 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 3,402,935 shares Expires 2027-06-13 F1 · kind: Gift from Dr. Boynton for estate planning purposes. Read SEC document |
| July 02, 2020 Filed Jul 3, 2020 01:55 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GrantOptions to purchase Common Stock, par value $0.001 · Derivative | 2,491,338 | $0.00 Strike: $0.21 | $0.00 |
DisclosureSEC source: 0001104659-20-080808 · tm2022243d8_4.xml · derivative · entry 2 BOYNTON ALTON L · CIK 0001253935 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,491,338 Underlying: Common Stock, par value $0.001 · 2,491,338 shares Expires 2030-07-02 F2 · kind: These options were approved in January 2020. The exercise price was determined based upon the pricing in year-end financings with unrelated investors. However, these options have not been executed and implemented (granted) until now. Read SEC document |
| July 02, 2020 Filed Jul 3, 2020 01:55 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GrantOptions to purchase Common Stock, par value $0.001 · Derivative | 605,160 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001104659-20-080808 · tm2022243d8_4.xml · derivative · entry 1 BOYNTON ALTON L · CIK 0001253935 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 605,160 Underlying: Common Stock, par value $0.001 · 605,160 shares Expires 2030-07-02 F1 · kind: These options were already approved and publicly reported in 2018. The exercise price was determined with reference to the pricing for unrelated investors at that time. However, the documents to implement and issue (grant) them have not been executed until now. Read SEC document |
| July 02, 2020 Filed Jul 3, 2020 01:55 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GrantOptions to purchase Common Stock, par value $0.001 · Derivative | 15,697,693 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001104659-20-080807 · tm2022243d7_4.xml · derivative · entry 1 BOYNTON ALTON L · CIK 0001253935 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,697,693 Underlying: Common Stock, par value $0.001 · 15,697,693 shares Expires 2030-12-01 F1 · kind: These options were awarded in part for service during the last 2 years. However, the documents to implement and issue (grant) them have not been executed until now. The $0.25 exercise price was determined with reference to the pricing for unrelated investors at the time of approval, which was the trailing 10-day average closing market price of the Company's stock, which was about $0.22. These options are subject to certain vesting requirements. They are also suspended and will not become exercisable until December 1, 2020. Read SEC document |
| May 28, 2018 Filed May 31, 2018 01:58 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GrantOptions to purchase Common Stock, par value $0.001 · Derivative | 4,900,000 | Not disclosed Strike: $0.23 | Not disclosed |
DisclosureSEC source: 0001144204-18-031800 · tv495284_4.xml · derivative · entry 1 BOYNTON ALTON L · CIK 0001253935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,270,000 Underlying: Common Stock, par value $0.001 · 4,900,000 shares Expires 2028-05-28 F1 · shares: Half of the Options are vested at the time of issuance and half will vest monthly over the course of 24 months from the date of Board approval, subject to acceleration in certain circumstances. F2 · price: The exercise price of the Options is $0.23. Read SEC document |
| June 13, 2017 Filed Jun 16, 2017 01:25 UTC | NORTHWEST BIOTHERAPEUTICS INC NWBO · Entity 5982 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,402,935 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001144204-17-032807 · v469119_4.xml · derivative · entry 1 BOYNTON ALTON L · CIK 0001253935 · Director · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,402,935 Underlying: Common Stock · 3,402,935 shares Expires 2022-06-13 F1 · derivative.exercise_date: The option's vesting schedule is as follows: 50% vested upon the date of grant with the remaining 50% vesting over a 24-month period in equal monthly installments Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.